0001782250-23-000002.txt : 20231226 0001782250-23-000002.hdr.sgml : 20231226 20231222204614 ACCESSION NUMBER: 0001782250-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231222 EFFECTIVENESS DATE: 20231226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lucy Therapeutics, Inc. CENTRAL INDEX KEY: 0001782250 ORGANIZATION NAME: IRS NUMBER: 822363951 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500678 FILM NUMBER: 231511187 BUSINESS ADDRESS: STREET 1: 501 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-249-4812 MAIL ADDRESS: STREET 1: 501 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001782250 Lucy Therapeutics, Inc. 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 617-249-4812 DELAWARE None None Corporation true Amy Ripka 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 Executive Officer Director Rachel Sha 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 Director John Ripple 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 Director Pharmaceuticals Decline to Disclose 06b false 2023-12-15 false true true false 0 9000000 3449999 5550001 false 3 0 0 0 false Lucy Therapeutics, Inc. Amy Ripka Amy Ripka President 2023-12-22